A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) (Q34758768)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) |
scientific article |
Statements
1 reference
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial) (English)
1 reference
Jacques Banchereau
1 reference
Rolando Cimaz
1 reference
Florence Allantaz
1 reference
Pascal Pillet
1 reference
Claude Messiaen
1 reference
Christophe Bardin
1 reference
Xavier Bossuyt
1 reference
Anne Boutten
1 reference
Jacques Bienvenu
1 reference
Agnes Duquesne
1 reference
Olivier Richer
1 reference
Agnes Mogenet
1 reference
Jean-Marc Treluyer
1 reference
Paul Landais
1 reference
Virginia Pascual
1 reference
20 December 2010
1 reference
1 reference
70
1 reference
5
1 reference
747-754
1 reference
Identifiers
1 reference
1 reference
1 reference